Search for: "Organon Pharmaceuticals USA Inc "
Results 1 - 15
of 15
Sorted by Relevance
|
Sort by Date
18 Dec 2013, 2:13 pm
Serious Injury And Death Cases Involve Blood Clots Leading To DVT And/Or PE Events As Well As Heart Attacks And Strokes In Women Of Various Ages (Posted by Tom Lamb at DrugInjuryWatch.com)The Form 10-Q SEC filing by Merck for the corporate quarterly period ending September 30, 2013 (93 page PDF document) provides us with this latest information about the number of filed NuvaRing lawsuits: As previously disclosed, beginning in May 2007, a number of complaints were filed in various jurisdictions… [read post]
13 Nov 2008, 2:25 pm
The NuvaRing's manufacturer and related companies are the defendants: Organon USA, Inc., Organon Pharmaceuticals USA, Inc., and Organon International, Inc. are being sued for not taking into account the higher level of hormone transference that occurs for users of the NuvaRing, and therefore not properly explaining the risk of using the NuvaRing in comparison to other methods of birth control such as the pill. [read post]
24 Oct 2012, 10:02 am
District Court Judge Rodney Sippel. (10/30/12) ______________________________________________________________________________ In a defeat for Defendants Organon USA Inc., Organon Pharmaceuticals USA Inc., and Organon International Inc. [read post]
20 Apr 2010, 5:07 pm
The lawsuit complaints allege that the parties named as defendants, which includes Organon USA, Inc., Organon Pharmaceuticals USA, Inc., Organon International, Inc., Akzo Nobel NV, Organon Biosciences, N.V., and Schering-Plough Corporation, not only knew about the potential side effects associated with NUVARING®, but concealed those risks from the public, including the FDA during the approval process. … [read post]
14 Apr 2012, 11:13 am
Dawn Kregel, a nurse, filed suit against Organon USA Inc., Organon Pharmaceuticals USA Inc., Organon International Inc., Schering-Plough Corp. and Merck & Co. [read post]
20 May 2013, 7:58 am
The complaints against NuvaRing began in May 2007 and were filed asserting claims against Organon USA, Organon Pharmaceuticals USA, Inc., Organon International. [read post]
28 Feb 2011, 6:58 pm
Organon, which is a wholly owned subsidiary of Merck & Co., Inc. and is related to Organon USA, Inc. and Schering Plough Corporation. [read post]
3 Nov 2011, 10:44 am
MANUFACTURERS: Organon Pharmaceuticals USA Inc., Organon USA Inc., Organon International Inc., Schering Plough Corp., and Akzo Nobel NV. [read post]
28 Mar 2011, 1:57 pm
Form 10-K Annual Report For the Fiscal Year Ended December 31, 2010, which was filed with the Securities and Exchange Commission on February 28, 2011: Beginning in May 2007, a number of complaints were filed in various jurisdictions asserting claims against the Company’s subsidiaries Organon USA, Inc., Organon Pharmaceuticals USA, Inc., Organon International (collectively, “Organon”), and… [read post]
18 Jul 2012, 12:17 pm
The NuvaRing’s manufacturer and related companies are the defendants: Organon USA, Inc., Organon Pharmaceuticals USA, Inc., and Organon International, Inc. are being sued for not taking into account the higher level of hormone transference that occurs for users of the NuvaRing and not properly explaining the risk of using the NuvaRing in comparison to other methods of birth control such as the pill. [read post]
18 Jul 2012, 12:17 pm
The NuvaRing’s manufacturer and related companies are the defendants: Organon USA, Inc., Organon Pharmaceuticals USA, Inc., and Organon International, Inc. are being sued for not taking into account the higher level of hormone transference that occurs for users of the NuvaRing and not properly explaining the risk of using the NuvaRing in comparison to other methods of birth control such as the pill. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
1 Oct 2009, 2:14 am
Organon USA, Inc., 2007 WL 4365312 (D.N.J. [read post]
27 Jul 2012, 12:40 pm
Cephalon, Inc., 2010 WL 1257790, at *6 (D.N.J. [read post]
7 Jan 2010, 10:36 am
Wyeth, Inc., 2007 WL 2458021 (E.D. [read post]
